biotech
Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech
January 15, 2026Sales and Marketing Arkin Capital, biotech
Arkin Capital has announced the closing of Arkin Bio Ventures III, a $100m fund designed to invest in pre-clinical and …
Cellbyte raises $2.75m to fund pharma drug launch platform
November 27, 2025Product launch AI, Cellbyte, biotech
Cellbyte has announced that it has raised $2.75m in seed funding for the streamlining of pharmaceutical drug launches. The complexity …
Richmond Pharmacology appoints Dr Edward Jackson as Medical Director
November 7, 2025CRO, Richmond Pharmacology, biotech, clinical trials
Richmond Pharmacology, a contract research organisation (CRO) specialising in first-in-human and adaptive clinical trials, has appointed Dr Edward Jackson as …
Lilly opens fourth US Gateway Labs site
September 26, 2025Research and Development Eli Lilly, Local Investment, biotech, life sciences
Eli Lilly has opened its newest Lilly Gateway Labs (LGL) site in San Diego, California, expanding its network of shared …
LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence
September 19, 2025Medical Communications, Research and Development LGC Group, biotech, life sciences, pharma
LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of Excellence in Ontario, Canada after …
Crown Bioscience opens new US model development centre
September 19, 2025Medical Communications, Research and Development CRO, biotech, crown bioscience, life sciences
Crown Bioscience, a US global contract research organisation (CRO) that is part of JSR Life Sciences and Japan-based JSR Corporation, …
Sapio Sciences and Ultima Genomics form multi-omics research partnership
September 11, 2025Medical Communications, Research and Development Sapio Sciences, Ultima Genomics, biotech, genomics research
Sapio Sciences and Ultima Genomics have formed a strategic partnership to accelerate genomics research. The collaboration aims to make multi-omics …
MultiOmic Health and BIO4 Campus sign collaborative Memorandum of Understanding
September 8, 2025Medical Communications, Research and Development AI, BIO4 Campus, Memorandum of Understanding, MultiOmic Health, biotech
MultiOmic Health (MOH), an artificial intelligence (AI)-enabled precision medicine biotechnology company and BIO4 Campus (BIO4), a biotechnology and life sciences …
ANGLE’s Parsortix system used in new cancer biology research
June 10, 2025Medical Communications, Research and Development Angle, Oncology, Parsortix system, R&D, biotech, oncology, scientific journals
ANGLE has announced three new peer-reviewed publications demonstrating the use of its Parsortix circulating tumour cell (CTC) harvesting system in …
Neogap Therapeutics selected to join EIC Soft-landing Programme, supporting international growth
May 15, 2025Medical Communications, Sales and Marketing Corporate, European Innovation Council (EIC), Immunology, Neogap Therapeutics, US pharma market, biotech, immunotherapy
Swedish biotech company, Neogap Therapeutics, has been selected to participate in the EIC Soft-landing Programme for Healthcare and Life Sciences …
Terumo’s plasma donation system adopted by Join Parachute to expand access to lifesaving therapies
May 13, 2025Biotech/start-up, Sales and Marketing Haematology, Join Parachute, Pharmacy, Terumo Blood and Cell Technologies (Terumo BCT), biotech, plasma donation
US Biotech company, Terumo Blood and Cell Technologies (Terumo BCT), has announced that Join Parachute will adopt its Rika Plasma …
Neogap chosen for Innovate Nordics 2025 Acceleration Programme
May 1, 2025Research and Development Innovate Nordics, Neogap Therapeutics, Oncology, biotech, funding programme, immunotherapy
Swedish biotech company Neogap Therapeutics has been chosen to join Innovate Nordics’ 2025 acceleration programme, a prestigious initiative designed to …
Neurizon makes appointments to executive team
April 24, 2025Recruitment, Senior Management Neurizon, Neurology, als, biotech, neurodegenerative diseases
Neurizon Therapeutics, a clinical-stage biotech company focusing on treatments for neurodegenerative diseases, has announced three leadership appointments. These will support …
Successful trial results announced for potential rare eye disease treatment
April 14, 2025Research and Development Eyestem, Opthalmology, age-related macular degeneration (AMD), biotech, cell therapy, eye disease
Eyestem Research, an Indian biotech company, announced successful results from its phase 1 trial of Eyecyte-RPE, a potential therapy for …
Infinitopes launches first-in-human trial of vaccine targeting oesophageal cancer
April 9, 2025Research and Development Infinitopes, Oncology, biotech, oesophageal cancer, oncology
The cancer biotech company Infinitopes has gained approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to evaluate …
Latest content
